Table 2.

Age at onset of ESRD in the young population in Taiwan, by sex and cause (n=2304, 1998–2009)

VariableAll (n=1049 [Female] and n=1255 [Male])Infant (n=6 [Female] and n=9 [Male])Toddler (n=6 [Female] and n=3 [Male])Preschool (n=6 [Female] and n=6 [Male])School Age (n=43 [Female] and n=51 [Male])Adolescent (n=109 [Female] and n=166 [Male])Young Adult (n=879 [Female] and n=1020 [Male])
Female
 Glomerulonephropathy669 (63.8)4 (66.7)2 (33.3)2 (33.3)26 (60.5)77 (70.6)558 (63.5)
 Genetic and metabolic diseases113 (10.8)1 (16.7)4 (9.3)7 (6.4)101 (11.5)
 Congenital anomalies (CAKUT)37 (3.5)2 (33.3)2 (33.3)3 (50.0)9 (20.9)8 (7.3)13 (1.5)
 Tumor19 (1.8)1 (2.3)18 (2.0)
 Nephrolithiasis7 (0.7)7 (0.8)
 Trauma1 (0.1)1 (0.1)
 ESRD with hypertension203 (19.4)2 (33.3)3 (7.0)17 (15.6)181 (20.6)
Male
 Glomerulonephropathy743 (59.2)7 (77.8)2 (66.7)3 (50.0)27 (52.9)103 (62.0)601 (58.9)
 Genetic and metabolic diseases120 (9.6)1 (11.1)1 (16.7)4 (7.8)8 (4.8)106 (10.4)
 Congenital anomalies (CAKUT)68 (5.4)1 (33.3)2 (33.3)13 (25.5)25 (15.1)27 (2.6)
 Tumor17 (1.4)1 (11.1)4 (2.4)12 (1.2)
 Nephrolithiasis23 (1.8)1 (2.0)22 (2.2)
 Trauma4 (0.3)1 (0.6)3 (0.3)
 ESRD with hypertension280 (22.3)6 (11.8)25 (15.1)249 (24.4)
  • Values are expressed as number (percentage) of patients.